Ticagrelor: The First Reversibly Binding Oral P2Y(12) Receptor Antagonist

por Husted, Steen, van Giezen, JJJ
Publicado 2009

Leveraging Human Genetics to Estimate Clinical Risk Reductions Achievable by Inhibiting Factor XI

por Georgi, Benjamin, Mielke, Johanna, Chaffin, Mark, Khera, Amit V., Gelis, Lian, Mundl, Hardi, van Giezen, J.J.J., Ellinor, Patrick, Kathiresan, Sekar, Ziegelbauer, Karl, Freitag, Daniel F.
Publicado 2019